Back to search results

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Head and Neck Squamous Cell Carcinoma · Recurrent Head and Neck Squamous Cell Carcinoma · Metastatic Head-and-neck Squamous-cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Ashley Fansler) · Ashley.Fansler@Advocatehealth.org
    Contact: Principal Investigator (Mercedes Porosnicu, MD)
Study leads

  • Mercedes Porosnicu, MD

    Principal Investigator

    Wake Forest University Health Sciences

View source on ClinicalTrials.gov(opens in a new tab)